Minutes for the Research for Patient Benefit (RfPB) programme Yorkshire & North East Regional Advisory Committee meeting to discuss Stage 2 applications to Competition 47 and Stage 1 applications to Competition 48.
Date and Location
Friday 30 September 2022 Virtual Meeting
In attendance
Committee members
Professor Robert Hinchliffe
Dr Rebecca Abbott
Ms Ailsa Cameron
Associate Professor Edward Carlton
Dr Ashwin Dhanda
Dr Sean Ewings
Professor Jenny Freeman
Professor William Henley
Dr Elsa Marques
Dr Antonieta Medina-Lara
Dr Siobhan O’Dwyer
Mrs Carol-Anne Partridge
Dr Susie Pearce
Mr Philip Ruthen
Dr Jenny Scott
Mrs Hilary Shergold
Dr Sarah Voss
Secretariat
Mr Simon Goodwin (NIHR)
Dr Jennie Hejdenberg (NIHR)
Ms Bronwyn Matthews (NIHR)
Ms Sadika Aktar (NIHR)
Observers
Mrs Judy Wright - RDS YH
Dr Olga Kozlowska - RDS SC
Dr Jennifer Owen - Schools
Competition 47 Stage 2 applications considered
NIHR204384: A feasibility randomised control cluster trial of a relationships and sex education programme for children with special needs: Keep Safe 4 All.
Conflicts: Dr Sean Ewings left the room
Final outcome: Rejected
NIHR204368: OPTimising IMmunosuppression for older Adult kidney transpLant recipients (the OPTIMAL Trial): a feasibility study
Conflicts: Dr Elsa Marques
Final outcome: Rejected
NIHR204393: The development and evaluation of the first fertility preservation patient decision aid to support young males with cancer.
Conflicts: None
Final outcome: Conditional support
Competition 48 Stage 1 applications considered
NIHR204988: Randomised controlled feasibility trial of once weekly Semaglutide and a weight management programme to promote weight loss in women living with obesity from an ethnically diverse deprived inner city population seeking removal of long acting reversible contraception in order to plan pregnancy
Conflicts: None
Outcome: Invite to Stage 2
NIHR204991: COMPEERS: A cluster randomised feasibility study of COntingency Management and PEER Support to promote attendance, increase treatment engagement, and improve outcomes for people with dual diagnoses of psychosis and drug/alcohol problems (DDp).
Conflicts: Professor Antonieta Medina-Lara, Dr Jenny Scott left the room
Outcome: Invite to Stage 2
NIHR204896: CytOSponge after Metabolic and Obesity Surgery (COSMOS)
Conflicts: None
Outcome: Invite to Stage 2
NIHR205005: A feasibility randomised controlled trial assessing Acellular Dermal Matrix (ADM) use in Implant based breast Reconstruction Evaluation (ADMIRE Trial).
Conflicts: None
Outcome: Rejected
NIHR204979: Identifying opportunities for personalised, risk-based, long-term clinical follow-up in head and neck cancer: ten-year follow-up of the Head and Neck 5000 cohort.
Conflicts: Professor Robert J. Hinchliffe, Dr Elsa Marques left the room
Outcome: Rejected
NIHR204972: A mixed methods study to optimise and explore digital follow up post-vascular surgery (Digi-Vasc)
Conflicts: Professor Robert J. Hinchliffe remained out of the room
Outcome: Rejected
NIHR204955: The co-development of best practice communication about Epilepsy and Risk to activate patient self-care for all people with Epilepsy
Conflicts: Professor Antonieta Medina-Lara, Professor William Henley left the room
Outcome: Rejected
NIHR204986: Risk of suicide and self-harm in substance misuse: development of two risk prediction rules and their feasibility in clinical practice
Conflicts: None
Outcome: Rejected
NIHR204997: Predicting type 2 diabetes mellitus risk after gestational diabetes
Conflicts: None
Outcome: Invite to Stage 2
NIHR204975: Inclusivity in Stroke Self-Management Support (ISSMAS): Co-designing resources to improve self-management by black African and Afro-Caribbean communities living with stroke in the UK
Conflicts: Professor Jenny Freeman, Dr Sarah Voss left the room
Outcome: Invite to Stage 2
NIHR204959: Assessing the Delivery of Pulmonary Rehabilitation using Hybrid versus Outpatient Centre-based approaches – a non-inferiority, randomised controlled trial (ADHOC study).
Conflicts: None
Outcome: Rejected
NIHR204940: Communication of benefits, side effects, and risks of medicines in primary care: a secondary analysis of data from the ‘One in a Million’ and Health Experience Research Group Archives
Conflicts: Dr Sarah Voss, Professor Antonieta Medina-Lara left the room
Outcome: Rejected
NIHR204953: Ensuring appropriate assessment of perimenopause and menopause in women with a serious mental illness (SMI) diagnosis
Conflicts: None
Outcome: Rejected
NIHR204913: Developing a peer-led digital mentoring service for digitally excluded service users
Conflicts: Mr Phil Ruthen left the room
Outcome: Rejected
Stage 2
| Score | Range | Number of applications |
|---|---|---|
| 9.0 - 10.0 | Fundable | 0 |
| 8.0 - 8.9 | Fundable | 0 |
| 7.0 - 7.9 | Fundable | 1 |
| 6.0 - 6.9 | Fundable | 0 |
| 5.0 - 5.9 | Rejected | 1 |
| 4.0 - 4.9 | Rejected | 1 |
| 3.0 - 3.9 | Rejected | 0 |
| 2.0 - 2.9 | Rejected | 0 |
| 1.0 - 1.9 | Rejected | 0 |
Stage 1
| Score | Range | Number of applications |
|---|---|---|
| 9.0 - 10.0 | Invited | 0 |
| 8.0 - 8.9 | Invited | 1 |
| 7.0 - 7.9 | Invited | 1 |
| 6.0 - 6.9 | Invited | 3 |
| 5.0 - 5.9 | Rejected | 3 |
| 4.0 - 4.9 | Rejected | 4 |
| 3.0 - 3.9 | Rejected | 2 |
| 2.0 - 2.9 | Rejected | 0 |
| 1.0 - 1.9 | Rejected | 0 |